Robert N. Wilson

Robert N. Wilson has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Schwab Charles Corp, Madrigal Pharmaceuticals, Inc. and Hess Corp. Over a trading history stretching from 30 January 2006 to 25 June 2026, the count stands at 84 filings.

Purchases make up the whole of the open-market record (17 purchases, €2.4M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 53 share grants and 13 option exercises.

The median purchase comes to €80k. 5 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 29 June 2026 came the latest disclosure, a share grant in CalciMedica, Inc. The latest purchase dates back some time: it was published 463 days ago, on 18 July 2025. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.